Teva has said it will defend itself against a lawsuit raised by 44 US states that alleges the company was the ringleader in an illegal price-fixing scheme involving 19 other generic compani
Novartis and Amgen have become embroiled in a legal row over rights to the migraine prevention drug Aimovig, as sales of a new class of injected drugs begin to mount.
Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.